Skip to main content

February 2012 Vol 5, No 1, Special Issue

Chronic Myeloid Leukemia: Are We Close to Finding a Cure?
Neil Canavan, Neil Canavan
Read More
Hematologic Pipeline Abundant
Caroline Helwick, Caroline Helwick
Read More
Conference Highlights ASH
VTE Prophylaxis during Chemotherapy Cost-Effective
Caroline Helwick, Caroline Helwick
Read More
Conference Highlights ASH
Favorable Data for Ruxolitinib and for a New JAK Inhibitor in Myelofibrosis
Neil Canavan, Neil Canavan
Read More
Multiple Myeloma, Multiple Myeloma, Oncology
Next-Generation Proteasome Inhibitors Cause Less Peripheral Neuropathy
Caroline Helwick, Caroline Helwick
Read More
Conference Highlights ASH
Genetic Profiles Linked to Hematologic Outcomes
Caroline Helwick, Caroline Helwick
Read More
Multiple Myeloma, Multiple Myeloma, Oncology
Future Directions in Myeloma
Caroline Helwick, Caroline Helwick
Read More
Conference Highlights ASH
DVT Prophylaxis: First Comparison of Catheter- Directed Thrombolysis versus Standard Care
Neil Canavan, Neil Canavan
Read More
Leukemia, Oncology
Ponatinib Overcomes Hard-to-Treat T315I Mutation in Patients with CML/ALL
Neil Canavan, Neil Canavan
Read More
Page 3 of 3
Results 21 - 29 of 29